Aflac Incorporated (NYSE:AFL) Shares Purchased by Creekmur Asset Management LLC

Creekmur Asset Management LLC increased its position in shares of Aflac Incorporated (NYSE:AFL) by 10,946.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,744 shares of the financial services provider’s stock after purchasing an additional 5,692 shares during the period. Creekmur Asset Management LLC’s holdings in Aflac were worth $493,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of AFL. Motley Fool Asset Management LLC lifted its stake in shares of Aflac by 5.9% in the 1st quarter. Motley Fool Asset Management LLC now owns 17,048 shares of the financial services provider’s stock valued at $1,464,000 after purchasing an additional 956 shares during the last quarter. Bayesian Capital Management LP purchased a new stake in Aflac in the 1st quarter valued at about $270,000. Kinloch Capital LLC lifted its position in Aflac by 4.6% in the first quarter. Kinloch Capital LLC now owns 51,392 shares of the financial services provider’s stock valued at $4,413,000 after buying an additional 2,241 shares during the last quarter. Captrust Financial Advisors boosted its stake in Aflac by 0.7% during the first quarter. Captrust Financial Advisors now owns 980,236 shares of the financial services provider’s stock worth $84,163,000 after buying an additional 7,163 shares during the period. Finally, Paloma Partners Management Co boosted its stake in Aflac by 110.0% during the first quarter. Paloma Partners Management Co now owns 10,711 shares of the financial services provider’s stock worth $920,000 after buying an additional 5,611 shares during the period. 67.44% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Morgan Stanley boosted their price target on shares of Aflac from $80.00 to $84.00 and gave the company an “equal weight” rating in a research note on Monday, April 15th. JPMorgan Chase & Co. upped their price target on Aflac from $80.00 to $83.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 2nd. Bank of America lifted their price objective on Aflac from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, July 11th. Citigroup boosted their price objective on Aflac from $84.00 to $93.00 and gave the company a “neutral” rating in a report on Tuesday, July 23rd. Finally, Keefe, Bruyette & Woods lifted their target price on Aflac from $83.00 to $87.00 and gave the company a “market perform” rating in a research report on Wednesday, April 10th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, Aflac presently has an average rating of “Hold” and a consensus target price of $86.46.

Insider Transactions at Aflac

In related news, Director Charles D. Lake II sold 22,378 shares of the stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $87.47, for a total value of $1,957,403.66. Following the transaction, the director now owns 61,522 shares of the company’s stock, valued at $5,381,329.34. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Joseph L. Moskowitz sold 600 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. The shares were sold at an average price of $84.84, for a total transaction of $50,904.00. Following the completion of the sale, the director now owns 27,550 shares in the company, valued at approximately $2,337,342. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Charles D. Lake II sold 22,378 shares of the stock in a transaction on Tuesday, May 21st. The shares were sold at an average price of $87.47, for a total transaction of $1,957,403.66. Following the completion of the transaction, the director now directly owns 61,522 shares in the company, valued at $5,381,329.34. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.

Aflac Stock Down 0.0 %

Shares of AFL traded down $0.02 during midday trading on Wednesday, hitting $95.34. The company had a trading volume of 4,508,601 shares, compared to its average volume of 2,197,640. Aflac Incorporated has a 1 year low of $71.97 and a 1 year high of $96.23. The firm has a market capitalization of $54.17 billion, a P/E ratio of 10.52, a P/E/G ratio of 2.58 and a beta of 0.95. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.08 and a current ratio of 0.08. The company’s 50-day simple moving average is $90.25 and its 200-day simple moving average is $85.47.

Aflac (NYSE:AFL) last issued its earnings results on Monday, May 6th. The financial services provider reported $1.66 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.08. Aflac had a net margin of 27.67% and a return on equity of 16.88%. The firm had revenue of $5.44 billion for the quarter, compared to analysts’ expectations of $4.09 billion. During the same quarter last year, the company earned $1.55 earnings per share. The firm’s revenue was up 13.3% compared to the same quarter last year. As a group, sell-side analysts expect that Aflac Incorporated will post 6.44 EPS for the current year.

Aflac Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.10%. Aflac’s dividend payout ratio (DPR) is currently 22.08%.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.